New Biotech Test for Prostate Cancer; Unlike PSA Test, is Ultra-Specific for Prostate Cancer

This article describes a more selective assay for prostate cancer. Unlike the PSA test which can simply indicate inflammation. This test measure the presence of a unique RNA derived from a gene fusion event which is specific to prostate cancer cells.